Select Page

Ubiquitin Antibody – MCA-Ubi-1

  • Clonality : Mouse Monoclonal
  • Applications : WB | IF/ICC | IHC
  • Reactivity : Human | Horse | Cow | Pig | Chicken | Rat | Mouse

310.00$1,660.00$ CAD

0 in stock (expect 7-14 days for delivery)


Cashback Reward : Earn up to 166$!

Encor Mouse Monoclonal to Ubiquitin 

Ubiquitin is a highly conserved globular 76 amino acid protein of about 8.5 kDa molecular weight. It has a important role in the targeting of proteins for proteolytic degradation. Proteins to be degraded are covalently coupled to the C-terminus of ubiquitin by means of ubiquitin ligases. The ubiquitin itself is frequently also ubiquitinated, producing a polyubiquitin chain. The polyubquitinated complex is then recognized by a complex of degradative enzymes which together form the proteosome. Interestingly, ubiquitin also becomes covalently bonded to many types of pathological inclusions seen in serious human disease states which appear to be resistant to normal degradation, so that ubiquitin antibodies are very useful for studies of these inclusions. For example the neurofibrillary tangles and paired helical filaments diagnostic of Alzheimer’s disease, the Lewy bodies seen in Parkinson’s disease, and Pick bodies found in Pick’s disease are all heavily ubiquitinated and can all be readily visualized with ubiquitin antibodies of appropriate specificity.

MCA-Ubi-1 was made in the University of Florida in 1987, and has been continuously on the market place since 1989, and is now being sold by several vendors. It has become widely used to study ubiquitinated inclusions seen in Alzheimer’s and other kinds of disease. MCA-Ubi-1 was raised against purified ubiquitin conjugated with glutaraldehyde to keyhole limpet hemocyanin. The clone was initially screened on ELISA of the immunogen, and subsequently tested on sections of Alzheimer brain. MCA-Ubi-1 was one of several clones which stained neurofibrillary tangles in frozen sectioned material strongly and specifically. Subsequent studies indicated that MCA-Ubi-1 is relatively insensitive to formalin fixation and so can be used on mildly fixed histological sections of human brain for studies of Alzheimer’s disease. The antibody also works on paraffin embedded material. MCA-Ubi-1 also recognizes other ubiquitinated inclusion bodies such as the Lewy bodies of Parkinson’s disease and the Pick bodies in Pick’s disease in formalin fixed tissues. MCA-Ubi-1 will recognize human, bovine, chicken, Drosophila, and C. elegans in ELISA. MCA-Ubi-1 also works on Western blots and can be used to study ubiquitinated proteins. It has also been successfully used in competitive ELISA. MCA-Ubi-1 is a mouse IgG1 with a k light chain.

HGNC name(s) : UBB, UBC

Host : Mouse

Clonality : Monoclonal

ID : EnCor Biotechnology Ubiquitin Ubi-1

Reactivity : Human | Horse | Cow | Pig | Chicken | Rat | Mouse

Isotype : IgG1

Conjugation : none

Immunogen : Purified bovine

Mass of detected protein : 8.5 kDa

Uniprot ID : P0CG47, P0CG48

KGNC name : UBB, UBC

RRID # : AB_2572391

Purification : Ascites

Storage : Shipped on ice. Store at 4°C. For long term storage, leave frozen at -20°C. Avoid freeze / thaw cycles.

Validated applications : WB | IF/ICC | IHC

Suggested Dilutions: 

WB: 1:1 000. IF/ICC and IHC: 1:1 000.


Link to on EnCor’s website 

References :

Perry, G. et al. Proc. Natl. Acad. Sci. USA 84, 3033-3036 (1987)
Shaw, G. and Chau, V. Proc. Natl. Acad. Sci. USA 85, 2854-2858 (1988)
Hirano, S., et al. Cell 70: 293-301 (1992)
Cuervo, A.M., et al. Mol. Biol. 9: 1995-2010 (1995)
Sternsdorf, T., et al. J. Cell Biol. 139: 1621-1634 (1997)
Tae-Wan Kim, et al. J. Biol. Chem. 272: 11006-11010 (1997)
Verdier, F., et al. J. Cell Biol. 273: 28185-28190 (1998)
Laroia, G., et al. Science 284: 499-502 (1999)
Marti, A., et al. Nature Cell Biol. 1: 14-19 (1999)
Sternsdorf, T., et al. Mol. Cell Biol. 19: 5170-5178 (1999)

Recent Papers using MCA-Ubi-1:

1. Fortun J, Go JC, Li J, Amici SA, Dunn WA Jr, Notterpek L. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis. 22:153-164 2006

2. Boutajangout A, Authelet M, Blanchard V, Touchet N, Tremp G, Pradier L, Brion JP. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer’s disease mutants of APP and presenilin-1. Neurobiol Dis. 15:47-60 (2004).

3. Wang DS, Bennett DA, Mufson EJ, Mattila P, Cochran E, Dickson DW. Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci. Res. 48:93-100 (2004).

4. He CZ, Hays AP. Expression of peripherin in ubiquinated inclusions of amyotrophic lateral sclerosis. J. Neurol. Sci. 217:47-54 (2004).

5. Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol. 22:3316-26 (2002)

6. Wirbelauer C, Sutterluty H, Blondel M, Gstaiger M, Peter M, Reymond F, Krek W. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J. 19:5362-75 (2000).

7. Harris KF, Shoji I, Cooper EM, Kumar S, Oda H, Howley PM. Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc Natl Acad Sci U S A. 96:13738-43 (1999).

8. Sternsdorf T, Puccetti E, Jensen K, Hoelzer D, Will H, Ottmann OG, Ruthardt M. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol. 19:5170-8 (1999).

9. Marti A, Wirbelauer C, Scheffner M, Krek W. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol. 1:14-9 (1999).

Additional information


50 ul, 100 ul, 500 ul








Ask a question about Ubiquitin Antibody – MCA-Ubi-1

Reviews for Ubiquitin Antibody – MCA-Ubi-1


    Be the first to review “Ubiquitin Antibody – MCA-Ubi-1”

    Your email address will not be published. Required fields are marked *